Sanofi-Aventis' Ambien CR, an extended-release formulation of the popular prescription sleep aid Ambien, is now available by prescription in pharmacies across the US for the treatment of insomnia.
Subscribe to our email newsletter
Ambien CR is non-narcotic and a non- benzodiazepine, formulated to offer a similar safety profile to Ambien with a new indication for sleep maintenance, in addition to sleep induction. In contrast to Ambien, Ambien CR is not limited to the short-term treatment of insomnia.
According to a recent National Sleep Foundation poll, more than one half (54%) of Americans said they experience at least one symptom of insomnia at least a few nights a week. In fact, one in five adults experienced difficulty falling asleep and one in three reported waking often during the night at least a few nights a week.
Ambien CR is a bi-layered tablet delivered in two stages. The first layer dissolves quickly to induce sleep. The second layer is released more gradually into the body to help provide more continuous sleep.